← Back to Search

Behavioral Intervention

Time restricted eating for Obstructive Sleep Apnea (TERESA Trial)

Q: What is the current number of participants enrolled in this clinical study?

Indeed, the details on clinicaltrials.gov indicate that this particular study is actively seeking suitable candidates. The trial was initially posted on January 5th, 2024 and recently updated on January 11th, 2024. The research team intends to recruit a total of 80 patients from a single site.

Q: Is the enrollment for this clinical trial currently open?

Indeed, the information available on clinicaltrials.gov confirms that this trial is actively enrolling participants. The initial posting of the study was on January 5th, 2024 and it was last updated on January 11th, 2024. The objective is to recruit a total of 80 patients from one specific site.

Q: Can individuals younger than 70 years of age participate in this medical study?

To be eligible for participation in this trial, applicants must fall between the ages of 18 and 70. It's noteworthy that there are a total of 44 studies focusing on patients under the age of 18 and an additional 224 studies specifically targeting individuals over the age of 65.

Phase < 1

Recruiting

Led By Omar Mesarwi, MD

Research Sponsored by University of California, San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have untreated moderate to severe obstructive sleep apnea (OSA, apnea-hypopnea index ≥15 events/hr);

Be of appropriate age (18-70);

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

TERESA Trial Summary

This trial aims to investigate the effects of a specific eating pattern called time restricted eating (TRE) on patients with obstructive sleep apnea (OSA). OSA is a common disorder that can

Who is the study for?

This trial is for adults aged 18-70 with untreated moderate to severe obstructive sleep apnea (OSA). Participants must be willing to follow the study procedures, own a smartphone, and have an eating period of over 12 hours per day. They cannot change doses of any cardiovascular medications during the study.Check my eligibility

What is being tested?

The trial is testing if time restricted eating (TRE) can improve glucose regulation and cardiovascular health in OSA patients compared to standard eating habits. It involves following a TRE plan for 12 weeks and uses smartphones for tracking.See study design

What are the potential side effects?

While not explicitly mentioned, potential side effects may include hunger, fatigue, or irritability due to changes in eating patterns. Changes in metabolism could also affect energy levels and mood.

TERESA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have moderate to severe sleep apnea that hasn't been treated.

Select...

I am between 18 and 70 years old.

Select...

I am on heart or blood pressure medication and won't change the dose during the study.

TERESA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Effect of TRE on quality of life

Effect of TRE vs SE on change in OSA severity

Effect of TRE vs SE on change in mean daily glucose level

+1 more

TERESA Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Time restricted eatingExperimental Treatment1 Intervention

Caloric intake restricted to a self-defined 8-10 hour window in each 24-hour period, for 12 weeks.

Group II: Standard eatingActive Control1 Intervention

Normal eating schedule. Participants are expected to maintain their normal eating and dietary habits.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Time restricted eating

2021

N/A

~130

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor

1,122 Previous Clinical Trials

1,520,964 Total Patients Enrolled

Omar Mesarwi, MDPrincipal InvestigatorUniversity of California, San Diego

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants enrolled in this clinical study?

"Indeed, the details on clinicaltrials.gov indicate that this particular study is actively seeking suitable candidates. The trial was initially posted on January 5th, 2024 and recently updated on January 11th, 2024. The research team intends to recruit a total of 80 patients from a single site."

Answered by AI

Is the enrollment for this clinical trial currently open?

"Indeed, the information available on clinicaltrials.gov confirms that this trial is actively enrolling participants. The initial posting of the study was on January 5th, 2024 and it was last updated on January 11th, 2024. The objective is to recruit a total of 80 patients from one specific site."

Answered by AI

Can individuals younger than 70 years of age participate in this medical study?

"To be eligible for participation in this trial, applicants must fall between the ages of 18 and 70. It's noteworthy that there are a total of 44 studies focusing on patients under the age of 18 and an additional 224 studies specifically targeting individuals over the age of 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Time Restricted Eating in Sleep Apnea

Omar Mesarwi 2024. "Time Restricted Eating in Sleep Apnea". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06047496.

All > Osa > Sleep Apnea